Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$5.17M$5.17Mderived+20.8% vs Q4 2021 Net Income-$4.39M-$4.39MderivedN/M vs Q4 2021 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$3,366,000+5.4% Operating Incomederived-$4,469,000N/M Operating Cash Flowderived-$3,065,000N/M Free Cash Flowderived-$3,104,000N/M Margins · derivedGross margin65.1%−9.5 pt vs Q4 2021
Operating margin-86.4%+6.6 pt vs Q4 2021
Net margin-84.8%+12.1 pt vs Q4 2021
ended Dec 31, 2022 · filed Mar 1, 2023 · 60 d after period end